Norbert W. Bischofberger, EVP, R&D and CSO at GILEAD SCIENCES INC (GILD), sold 90,000 shares at $67.23 ($6.0M) on 2014-04-14, disclosed to the SEC on 2014-04-16.
Scheduled sale ($6.0M) by EVP, R&D and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.47 | 31,990 | $2.1M | 35.2% |
| 2 | $67.23 | 50,307 | $3.4M | 56.1% |
| 3 | $68.01 | 7,703 | $524K | 8.7% |
| Total | $67.03 avg | 90,000 | $6.0M | 100% |
| Filing → |
| KRON | BUY | 2023-11-17 | $2.7M | — | Filing → |
| KRON | BUY | 2022-05-19 | $3.4M | — | Filing → |
| KRON | BUY | 2021-12-08 | $347K | — | Filing → |